Highlights
- Market Cap
- $3.47B
- Enterprise Value
- $3.36B
- EPS (TTM)
- $0.31
- PE Ratio
- 43.99
- PEG Ratio
- 0.09
- Total Revenue (TTM)
- $475.68M
- Gross Profit (TTM)
- $400.50M
- EBITDA (TTM)
- $83.65M
- Year Range
- $11.76 - $20.53
- Target Price
- $20.67
- ROA (TTM)
- 8.34%
- ROE (TTM)
- 16.17%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Cellebrite DI Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Cellebrite DI Ltd. (CLBT) has returned -23.57% so far this year and -29.08% over the past 12 months.
Cellebrite DI Ltd.
- 1D
- 4.16%
- 1M
- 3.30%
- YTD
- -23.57%
- 6M
- -25.63%
- 1Y
- -29.08%
- 3Y*
- 31.28%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Aug 31, 2021, CLBT's average daily return is +0.07%, while the average monthly return is +1.52%. At this rate, your investment would double in approximately 3.8 years.
Historically, 51% of months were positive and 49% were negative. The best month was Feb 2024 with a return of +32.4%, while the worst month was Nov 2021 at -30.2%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 3 months.
On a daily basis, CLBT closed higher 49% of trading days. The best single day was Nov 13, 2025 with a return of +20.7%, while the worst single day was Apr 6, 2022 at -13.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -18.41% | -9.31% | 3.30% | -23.57% | |||||||||
| 2025 | 9.12% | -22.80% | 4.69% | 1.85% | -15.72% | -4.08% | -12.62% | 17.31% | 12.99% | -7.93% | -1.17% | 6.94% | -18.16% |
| 2024 | 4.39% | 32.41% | -7.44% | -2.44% | -1.48% | 12.21% | 14.64% | 24.53% | -1.29% | 7.78% | 11.18% | 9.17% | 154.39% |
| 2023 | 25.92% | 12.02% | -0.98% | -11.17% | 6.65% | 24.78% | 8.47% | 3.07% | -4.97% | -12.68% | 26.50% | 2.49% | 98.62% |
| 2022 | -25.19% | 18.33% | -9.86% | -16.41% | -9.91% | 5.81% | -0.98% | -3.96% | -19.18% | 23.21% | -6.42% | -3.54% | -45.64% |
| 2021 | -9.66% | 20.63% | -30.17% | 2.82% | -21.76% |
Benchmark Metrics
Cellebrite DI Ltd. has an annualized alpha of 10.05%, beta of 0.95, and R² of 0.11 versus S&P 500 Index. Calculated based on daily prices since September 01, 2021.
- This stock participated in 119.66% of S&P 500 Index downside but only 116.52% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.11 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 10.05%
- Beta
- 0.95
- R²
- 0.11
- Upside Capture
- 116.52%
- Downside Capture
- 119.66%
Return for Risk
Risk / Return Rank
CLBT ranks 14 for risk / return — in the bottom 14% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Cellebrite DI Ltd. (CLBT) and compare them to a chosen benchmark (S&P 500 Index).
| CLBT | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.62 | 0.90 | -1.52 |
Sortino ratioReturn per unit of downside risk | -0.75 | 1.39 | -2.14 |
Omega ratioGain probability vs. loss probability | 0.91 | 1.21 | -0.30 |
Calmar ratioReturn relative to maximum drawdown | -0.72 | 1.40 | -2.12 |
Martin ratioReturn relative to average drawdown | -1.48 | 6.61 | -8.09 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore CLBT risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Cellebrite DI Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cellebrite DI Ltd. was 67.74%, occurring on Sep 30, 2022. Recovery took 355 trading sessions.
The current Cellebrite DI Ltd. drawdown is 47.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -67.74% | Sep 17, 2021 | 262 | Sep 30, 2022 | 355 | Mar 1, 2024 | 617 |
| -54.08% | Feb 6, 2025 | 262 | Feb 23, 2026 | — | — | — |
| -15.54% | Mar 4, 2024 | 32 | Apr 17, 2024 | 39 | Jun 12, 2024 | 71 |
| -13.52% | Sep 3, 2021 | 4 | Sep 9, 2021 | 5 | Sep 16, 2021 | 9 |
| -11.27% | Jul 29, 2024 | 6 | Aug 5, 2024 | 8 | Aug 15, 2024 | 14 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cellebrite DI Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Cellebrite DI Ltd. is priced in the market compared to other companies in the Software - Infrastructure industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CLBT, comparing it with other companies in the Software - Infrastructure industry. Currently, CLBT has a P/E ratio of 44.0. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CLBT compared to other companies in the Software - Infrastructure industry. CLBT currently has a PEG ratio of 0.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CLBT relative to other companies in the Software - Infrastructure industry. Currently, CLBT has a P/S ratio of 7.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CLBT in comparison with other companies in the Software - Infrastructure industry. Currently, CLBT has a P/B value of 7.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |